Early Access — free while we kick the tires
EdgarHawk

Dennis Cho

See Remarks

Officer

Latest: Officer selling · June 2026

1 filing analyzed · 1 company · Latest 2026-06-26

Never miss a filing from Dennis Cho

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Twist Bioscience Corp TWST 0 1 Net selling

Activity

June 2026
2026-06-26 Twist Bioscience Corp TWST 10b5-1 Plan
low
Sell
14,205 shares
$1,274,899
Significance 4/10

Dennis Cho sold 14,205 shares of TWST at $89.75 under pre-arranged 10b5-1 plan; retains 105,141 shares.

This sale of 14,205 shares was executed under a 10b5-1 trading plan adopted on 2026-02-17, meaning it was scheduled rather than discretionary. The transaction occurred at $89.75, below the current price of $99.84 and the 52-week high of $104.23. While Twist Bioscience posted annual revenue growth of +20.3% and recent quarterly revenue of $110,715,000.00, the company reported net income of $-44,021,000.00 and remains unprofitable on a full-year basis. Cho retains 105,141 shares post-transaction, maintaining a substantial equity stake despite the scheduled disposition.

Related insiders